Endometrial ablation

Last updated
Endometrial ablation
Endometrial Ablation.png
Schematic illustration of endometrial ablation
ICD-9-CM 68.23

Endometrial ablation is a surgical procedure that is used to remove (ablate) or destroy the endometrial lining of the uterus. The goal of the procedure is to decrease the amount of blood loss during menstruation (periods). Endometrial ablation is most often employed in people with excessive menstrual bleeding following unsuccessful medical therapy. [1] It is less effective than hysterectomy, but with a lower risk of adverse events. [2]

Contents

Endometrial ablation is typically done in a minimally invasive manner with no external incisions. Slender tools are inserted through the vagina and into the uterus. In some forms of the procedure, one of these tools may be a camera (hysteroscope) to assist with visualization. Other tools include those that harness electricity, high-energy radio waves, heated fluids, or cold temperature to destroy the endometrial lining. [3]

The procedure is almost always performed as an outpatient treatment, either at a hospital, ambulatory surgery center, or physician office. Patients will most commonly undergo local and/or light sedative anesthesia, or if necessary, general or spinal anesthesia. [4]

After the procedure, the endometrium heals by scarring over, thus reducing or eliminating future uterine bleeding. [5] The patient's hormonal functions will remain unaffected because the ovaries are left intact. Due to the uterine changes that take place after undergoing ablation, patients are unlikely to be able to become pregnant after the procedure, and of pregnancies that do occur, complication risk is high. To reduce the associated mortality risks, it is often recommended for patients to adhere to birth control methods after undergoing endometrial ablation. [4]

Indications

The primary indication for endometrial ablation is abnormal uterine bleeding, including chronic heavy menstrual bleeding, in premenopausal patients. [6] Typically, these are patients for whom first-line medical therapy was unsuccessful or contraindicated. [1]

In some cases, endometrial ablation is used to treat small uterine fibroids. [7]

Absolute contraindications for undergoing endometrial ablation include endometrial carcinoma, current pregnancy, and desire for future pregnancy. [5]

Preparation and planning

Prior to undergoing endometrial ablation, patients will go through a pre-procedure evaluation and risk assessment. Components of this often include informed consent, anesthesia evaluation, and a pregnancy test (as current pregnancy is a contraindication to the procedure). All patients will undergo endometrial sampling to test for endometrial carcinoma, as this is an absolute contraindication to endometrial ablation. Some patients may also require further assessment of the uterus through hysteroscopy or saline infusion sonohysterography, and/or removal of any current IUD.

Depending on the treatment that is chosen, endometrial ablation is sometimes conducted after treatment with hormones, such as norethisterone or Lupron to reduce the thickness of the endometrium. [8]

Procedure

Endometrial ablation may be done in-office or in an operating room. The procedure begins with cervical dilation, which temporarily stretches the cervix to make room for the ablation instruments and/or hysteroscope to enter the uterus. Dilation can be induced medically with pharmacologic agents, or mechanically with a series of metal tools of increasing diameter. After sufficient dilation, the ablation instrument is introduced into the uterine cavity, which is used to partially or fully destroy the endometrial lining. A hysteroscope may be used to assist in visualization of this process and/or ensure that final results are adequate. [9]

The technique utilized to remove or destroy the endometrium varies with endometrial ablation operations. Options consist of:

After the ablation procedure is complete, any concomitant procedures that patients have opted for will also be completed. A common procedure after endometrial ablation is IUD insertion, as effective contraception following endometrial ablation is highly recommended. Other concomitant procedures may include myomectomy and/or tubal ligation. [6]

Endometrial ablation is often an outpatient procedure that does not require an overnight hospital stay. Patients may experience cramping, vaginal discharge, and/or urinary changes during the recovery process. [11]

Technique

Hysteroscopic image of an endometrial ablation procedure Endometrial ablation 1.jpg
Hysteroscopic image of an endometrial ablation procedure

A number of treatment options are available, all of which work by inserting tools into the cervix to destroy the ablate the endometrium. [12] Commonly used ablation systems include:

Older methods utilize hysteroscopy to insert instruments into the uterus to destroy the lining under visualization using a laser, or microwave probe.

Effectiveness

The U.S. Food and Drug Administration approves and audits clinical studies to test and evaluate the effectiveness of all endometrial ablation treatments. Two patient effectiveness outcomes are measured at one year following treatment: 1) success rate = the % of people who have their bleeding reduced to a normal period level or less, and 2) amenorrhea rate = the % of people that have their bleeding eliminated. According to the results of the randomized controlled trials performed for the FDA approval of the different treatment options, effectiveness success rates range from a high of 93% to a low of 67%, and the amenorrhea rates range from a high of 72% to a low of 22%. [15] Compared with hysterectomy, ablation was less effective at reducing pain and excess bleeding; however, it also resulted in fewer adverse events. [2] Satisfaction rates following hysterectomy and ablation were similar. [2]

Complications

Although rare, the procedure can have complications [5] including:

See also

References

  1. 1 2 Bofill Rodriguez, Magdalena; Dias, Sofia; Jordan, Vanessa; Lethaby, Anne; Lensen, Sarah F; Wise, Michelle R; Wilkinson, Jack; Brown, Julie; Farquhar, Cindy (2022-05-31). Cochrane Gynaecology and Fertility Group (ed.). "Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis". Cochrane Database of Systematic Reviews. 2023 (2): CD013180. doi:10.1002/14651858.CD013180.pub2. PMC   9153244 . PMID   35638592.
  2. 1 2 3 Matteson, Kristen A.; Abed, Husam; Wheeler, Thomas L.; Sung, Vivian W.; Rahn, David D.; Schaffer, Joseph I.; Balk, Ethan M. (January 2012). "A Systematic Review Comparing Hysterectomy with Less-Invasive Treatments for Abnormal Uterine Bleeding". Journal of Minimally Invasive Gynecology. 19 (1): 13–28. doi:10.1016/j.jmig.2011.08.005. PMC   3269666 . PMID   22078015.
  3. Sharp, Howard T. (October 2006). "Assessment of New Technology in the Treatment of Idiopathic Menorrhagia and Uterine Leiomyomata". Obstetrics & Gynecology. 108 (4): 990–1003. doi:10.1097/01.AOG.0000232618.26261.75. ISSN   0029-7844. PMID   17012464.
  4. 1 2 ACOG Committee on Practice Bulletins (May 2007). "ACOG Practice Bulletin No. 81: Endometrial Ablation". Obstetrics & Gynecology. 109 (5): 1233–1248. doi:10.1097/01.AOG.0000263898.22544.cd. ISSN   0029-7844. PMID   17470612.
  5. 1 2 3 Sharp, Howard T. (October 2012). "Endometrial ablation: postoperative complications". American Journal of Obstetrics and Gynecology. 207 (4): 242–247. doi:10.1016/j.ajog.2012.04.011. ISSN   1097-6868. PMID   22541856.
  6. 1 2 Practice Committee of American Society for Reproductive Medicine (November 2008). "Indications and options for endometrial ablation". Fertility and Sterility. 90 (5 Suppl): S236–240. doi: 10.1016/j.fertnstert.2008.08.059 . ISSN   1556-5653. PMID   19007637.
  7. "Fibroids - Treatment". nhs.uk. 2017-10-20. Retrieved 2025-01-02.
  8. "Endometrial Ablation". www.hopkinsmedicine.org. 19 November 2019.
  9. Glasser, Mark H. (2009). "Practical tips for office hysteroscopy and second-generation "global" endometrial ablation". Journal of Minimally Invasive Gynecology . 16 (4): 384–399. doi:10.1016/j.jmig.2009.04.002. ISSN   1553-4650. PMID   19573815.
  10. 1 2 3 4 5 6 "Endometrial ablation - Mayo Clinic". www.mayoclinic.org. Retrieved 2023-02-15.
  11. "NovaSure endometrial ablation". University of Iowa Hospitals & Clinics. Retrieved 2023-02-17.
  12. James F. Carter. "Endometrial Ablation: More Choices, More Options" (PDF). Archived from the original (PDF) on 2012-09-13. Retrieved 2012-12-19 via Boston Scientific. Edited version of the original CME article that appeared in The Female Patient. 2005; 30(12):35-40.
  13. "NovaSure® V5 Global Endometrial Ablation Device Approved for Use in Canada and Europe". investors.hologic.com. Retrieved 2025-01-02.
  14. "HTA Ablation". Centre for Women's Health – Wichita. Archived from the original on 2 January 2015. Retrieved 15 September 2014.
  15. "FDA letter to Endometrial Ablation Industry" (PDF). Food and Drug Administration .